ABEV vs. KDP, STZ, BF.B, DEO, SYY, KVUE, CTVA, CCEP, GIS, and HSY
Should you be buying Ambev stock or one of its competitors? The main competitors of Ambev include Keurig Dr Pepper (KDP), Constellation Brands (STZ), Brown-Forman (BF.B), Diageo (DEO), Sysco (SYY), Kenvue (KVUE), Corteva (CTVA), Coca-Cola Europacific Partners (CCEP), General Mills (GIS), and Hershey (HSY). These companies are all part of the "consumer staples" sector.
Ambev (NYSE:ABEV) and Keurig Dr Pepper (NASDAQ:KDP) are both large-cap consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, community ranking, dividends, valuation, institutional ownership and earnings.
Ambev received 352 more outperform votes than Keurig Dr Pepper when rated by MarketBeat users. Likewise, 60.48% of users gave Ambev an outperform vote while only 34.33% of users gave Keurig Dr Pepper an outperform vote.
Ambev has a net margin of 18.25% compared to Keurig Dr Pepper's net margin of 14.52%. Ambev's return on equity of 17.53% beat Keurig Dr Pepper's return on equity.
Ambev has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500. Comparatively, Keurig Dr Pepper has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500.
8.1% of Ambev shares are owned by institutional investors. Comparatively, 85.2% of Keurig Dr Pepper shares are owned by institutional investors. 0.8% of Keurig Dr Pepper shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
In the previous week, Keurig Dr Pepper had 4 more articles in the media than Ambev. MarketBeat recorded 11 mentions for Keurig Dr Pepper and 7 mentions for Ambev. Keurig Dr Pepper's average media sentiment score of 0.91 beat Ambev's score of 0.55 indicating that Keurig Dr Pepper is being referred to more favorably in the news media.
Ambev has higher revenue and earnings than Keurig Dr Pepper. Ambev is trading at a lower price-to-earnings ratio than Keurig Dr Pepper, indicating that it is currently the more affordable of the two stocks.
Ambev presently has a consensus target price of $3.03, indicating a potential upside of 25.34%. Keurig Dr Pepper has a consensus target price of $36.64, indicating a potential upside of 8.55%. Given Ambev's higher probable upside, equities analysts plainly believe Ambev is more favorable than Keurig Dr Pepper.
Ambev pays an annual dividend of $0.25 per share and has a dividend yield of 10.3%. Keurig Dr Pepper pays an annual dividend of $0.86 per share and has a dividend yield of 2.5%. Ambev pays out 131.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Keurig Dr Pepper pays out 55.5% of its earnings in the form of a dividend.
Summary
Ambev and Keurig Dr Pepper tied by winning 10 of the 20 factors compared between the two stocks.
Get Ambev News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABEV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ABEV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
